From January 2007
MAXWELL BIOCORPORATION, LLC, & INTERNATIONAL MEDICAL
INFORMATION TECHNOLOGIES, INC., ANNOUNCE PARTNERSHIP
Sponsorship Agreement Promotes International Medical Education,
Helps Break Down Language Barrier
MaxWell Biocorporation, Washington, D.C., Friday, Aug 1, 2008
WASHINGTON, /PRNewswire/ -- Russian-speaking medical professionals around the world have a potent new ally to help them integrate into the English-speaking mainstream of global medical research.
Dr. Peter M. Leitner, President of MaxWell USA, LLC, and Dr. Marina Filshtinsky, President of Boston-based International Medical Information
Technologies, Inc. (IMIT) and editor-in-chief of MedMir.com, announced today a sponsorship deal between their two organizations.
MaxWell USA will provide the first significant outside funding received by IMIT since its 2005 inception. As a result, IMIT will be in a stronger position to supply timely, comprehensive, and free translations of leading medical journal articles to Russian-speaking medical professionals around the world.
By partnering, MaxWell and IMIT will contribute more effectively to improving the quality of healthcare offered by Russian-speaking medical providers to their patients wherever they may be.
ABOUT MEDMIR
MedMir.com (http://www.medmir.com) is the first project of the Boston-based nonprofit organization International Medical Information Technologies, Inc., IMIT (http://www.imithome.org). MedMir provides Russian-speaking medical professionals around the world with free access to timely, comprehensive, and accurate summaries of leading research papers from the world's top medical journals, translated by highly qualified medical specialists.
The MedMir project began in January 2005 and has consistently attracted a growing number of Russian-speaking medical professional visitors to its
website. MedMir is the only service on the Internet that provides timely, comprehensive international medical information in Russian. MedMir.com = World Medical Journal Reviews In Russian.
ABOUT MAXWELL BIOCORPORATION
MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union.
MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."
